Alterations in chemokine receptor expressions on peripheral blood monocytes in multiple sclerosis and neuromyelitis optica

Clinical and Experimental Neuroimmunology

Volumn 4, Issue 2, 2013, Pages 201-205

  Cui, Yi Wen ^a   Kawano, Yuji ^a   Shi, Nan ^a   Masaki, Katsuhisa ^a   Isobe, Noriko ^a   Yonekawa, Tomomi ^a   Matsushita, Takuya ^a   Tateishi, Takahisa ^a   Yamasaki, Ryo ^a   Murai, Hiroyuki ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

flow cytometry; monocyte; multiple sclerosis; neuromyelitis optica; surface marker

Indexed keywords

BETA INTERFERON; CD14 ANTIGEN; CD16 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; L SELECTIN; PREDNISOLONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAINTENANCE THERAPY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION;

EID: 84883318372     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12039     Document Type: Article

References (19)

1. Lassmann H, Brück W, Lucchinetti CF,. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007; 17: 210-8.
2. Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG,. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010; 16: 30-8.
3. Molnarfi N, Benkhoucha M, Bjarnadõttir K, Juillard C, Lalive PH,. Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients. PLoS ONE. 2012; 7: e49882.
4. Matsuoka T, Suzuki SO, Suenaga T, Iwaki T, Kira J,. Reappresal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients. Brain Pathol. 2011; 21: 516-32.
5. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116: e74-80.
6. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005; 58: 840-6.
7. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG,. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006; 66: 1485-9.
8. Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry. 2013; 84: 29-34.
9. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33: 1444-52.
10. Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, Yoshimura S, et al. Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica. Mult Scler. 2012; 18: 1541-51.
11. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 1997; 94: 12053-8.
12. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ,. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med. 2000; 192: 899-905.
13. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM,. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001; 193: 713-26.
14. Sørensen TL, Sellebjerg F,. Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis. Mult Scler. 2002; 8: 104-7.
15. Nakajima H, Sugino M, Kimura F, Hanafusa T, Ikemoto T, Shimizu A,. Decreased CD14+CCR2+ monocytes in active multiple sclerosis. Neurosci Lett. 2004; 363: 187-9.
16. Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, et al. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci. 2011; 31: 9910-22.
17. Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, et al. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002; 46: 2578-86.
18. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004; 50: 1457-67.
19. Li Y, Lee PY, Sobel ES, Narain S, Satoh M, Segal MS, et al. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther. 2009; 11: R6. doi: 10.1186/ar2590.